Documentos relacionados

1. Primary Prevention of Sudden Death in Patients With Valvular Cardiomyopathy.
2. Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion.
3. Use of subcutaneous cardioverter-defibrillator. First cases reported from National Institute of Cardiology Ignacio Chávez-Mexico.
4. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.
5. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance.
6. Sex differences and adherence of patients treated with wearable cardioverter-defibrillator: Insights from an international multicenter register.
7. Qué nos ha enseñado y qué nos queda por aprender del estudio PREDIMED
8. Avoiding implantation of a cardioverter-defibrillator by bridging with wearable defibrillator vest.
9. Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy.
10. A real world wearable cardioverter defibrillator experience - Very high appropriate shock rate in ischemic cardiomyopathy patients at a European single-center.